Recombinant MSG1 protein monoclonal antibody and blocked ELISA (Enzyme-linked Immuno Sorbent Assay) method for detecting haemophilus parasuis mycoplasma specific antibody
A monoclonal antibody, Mycoplasma haemophilus technology, applied in the field of serology, can solve the problem of lack of MSG1 protein monoclonal antibody, and achieve the effect of good repeatability, good specificity, and stable antibody secretion ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Example 1 Preparation of Mycoplasma suis recombinant MSG1 protein and detection protein
[0038] 1.1 Modification and artificial synthesis of MSG1 gene
[0039] According to the codon preference of E.coli and the obstacles encountered in the translation of tryptophan encoded by UGA, the entire MSG1 gene sequence was modified according to the degeneracy of codons, and at the same time at the 5' end and 3' end of the gene KpnI and EcoRI restriction sites were added at the 'end respectively, and the sequence is SEQ ID NO.2. The whole gene sequence was synthesized by Shanghai Jierui Bioengineering Co., Ltd.
[0040] 1.2 Cloning and identification of MSG1 gene
[0041] The pBAD / HisB vector (Invitrogen Company) was digested with KpnI and EcoRI and recovered from the gel, then the recovered vector was ligated with the synthesized MSG1 gene, the ligated product was transformed into DH5α competent cells, and the transformed product was coated with ampicillin On the resistance...
Embodiment 2
[0050] Example 2 Preparation of recombinant MSG1 protein monoclonal antibody against Mycoplasma suis
[0051] 2.1 Animal immunity
[0052] Take healthy BALB / c female mice aged 6-8 weeks (purchased from Nanjing Qingzilan Technology Co., Ltd.), and immunize them by subcutaneous multipoint injection. 100μg, three free 200μg. The antigen was emulsified with an equal volume of complete Freund's adjuvant for the first immunization, and the antigen was emulsified with an equal volume of incomplete Freund's adjuvant for the second and third immunizations. The interval between each immunization was 14 days, blood was collected from the tail vein 10 days after the third immunization, and the antibody titer was determined. Mice with a titer above 1:10000 were injected intraperitoneally with 200 μg of non-emulsified antigen 3 days before cell fusion for booster immunization.
[0053] 2.2 Indirect ELISA screening method
[0054] The antigen (recombinant MSG1 protein, prepared and purifi...
Embodiment 3
[0085] Example 3 Establishment of ELISA Detection Method for Mycoplasma Suis Enzyme-labeled Monoclonal Antibody Blocking
[0086] 3.1 Monoclonal antibody purification and horseradish peroxidase (HRP) labeling
[0087] The prepared ascites was sent to KingScript Bioengineering Company for purification and labeling of monoclonal antibody. The purity of the antibody reaches 97.6%. The results of SDS-PAGE analysis of ascitic fluid before and after purification are shown in Figure 5 .
[0088] 3.2 Selection of optimal reaction conditions for blocking ELISA
[0089] 3.2.1 Selection of optimal coating concentration of antigen and optimal dilution of serum
[0090] According to the checkerboard method, the purified recombinant MSG1 protein was diluted to the final concentrations of 2.0, 1.0, 0.5, and 0.25 μg / ml with carbonate buffer solution of pH 9.6, and coated overnight at 4°C. Then wash with 0.05mol / LPBS containing 0.05% Tween 20 (referred to as PBST, pH 7.2) for 5min×3 times...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com